* The American Food and Drug Administration has approved new epilepsy drug felbamate, marketed under the name Felbatol (Wallace Laboratories no relation to the Wallace Press, which publishes WDDTY), for treating epilepsy in adults and children. Side effects include headache, insomnia, dizziness, vomiting and abdominal pain. J Am Med Assoc, 13 October 1993.
* A 47 year old woman with no history of cardiovascular disease suffered from a heart attack after using sumatriptan, the new migraine "wonder" drug. Post marketing studies of sumatriptan have reported angina like pain and constriction of arteries. The Lancet, 30 October 1993.
* Health maintenance organization Kaiser Permanent Medical Care of Northern California has decided not to add Alzheimer's disease drug tacrine to its drug formulary. After evaluating the drug's efficacy, safety and cost, Dr William Elliot, who chaired the committee responsible for the decision, said, "Tacrine really flunked all three." The Lancet, 16 October 1993.
* Among a bevy of side effects, the latest for all purpose immunosuppressant cyclosporin could be in grown toenails. A 14 year old boy given the drug to treat aplastic anemia and easy bruising developed seven cases of ingrown toenails requiring surgery. The condition cleared up when the drug was stopped after the boy's kidney function deteriorated. 30 October 1993.